ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 145 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,863,000 | +37.6% | 250,000 | +150.0% | 0.03% | -9.1% |
| Q4 2016 | $2,080,000 | -15.4% | 100,000 | +33.3% | 0.03% | -21.4% |
| Q3 2016 | $2,458,000 | +31.2% | 75,000 | 0.0% | 0.04% | +20.0% |
| Q2 2016 | $1,873,000 | -49.5% | 75,000 | -41.6% | 0.04% | -50.0% |
| Q1 2015 | $3,707,000 | +397.6% | 128,461 | +401.9% | 0.07% | +366.7% |
| Q4 2014 | $745,000 | – | 25,596 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $40,160,000 | 10.45% |
| Foresite Capital Management II, LLC | 1,586,220 | $21,652,000 | 9.78% |
| DAFNA Capital Management LLC | 571,013 | $7,794,000 | 3.36% |
| Redmile Group, LLC | 8,244,896 | $112,543,000 | 3.29% |
| Lion Point Capital, LP | 1,271,500 | $17,355,000 | 1.57% |
| Palo Alto Investors LP | 1,861,630 | $25,411,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,185,983 | $43,488,000 | 1.03% |
| Bellevue Group AG | 1,286,748 | $17,564,000 | 0.97% |
| BB BIOTECH AG | 2,766,008 | $37,756,000 | 0.95% |
| Rock Springs Capital Management LP | 1,560,000 | $21,294,000 | 0.82% |